Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects.

Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects.
复制标题

DOI:
10.1002/cpt.2052
复制
发表时间:
2021-03
影响因子:
6.7
通讯作者:
Langer O
Langer O
中科院分区:
医学2区
文献类型:
--
作者:
Bauer M;Bamminger K;Pichler V;Weber M;Binder S;Maier-Salamon A;Tahir A;Jäger W;Haslacher H;Tournier N;Hacker M;Zeitlinger M;Langer O

文献摘要

参考文献

被引文献

相似文献

The antiemetic and gastroprokinetic drug metoclopramide is a weak substrate of the blood‐brain barrier (BBB) efflux transporter P‐gp and displays central nervous system (CNS) side effects (i.e., extrapyramidal symptoms and tardive dyskinesia) caused by dopamine D2 receptor blockade in the basal ganglia. These side effects occur with a higher incidence in elderly people. We used positron emission tomography to assess the brain distribution of [11C]metoclopramide in young (n = 11, 26 ± 3 years) and elderly (n = 7, 68 ± 9 years) healthy men both after administration of a microdose (9 ± 7 µg) and a microdose co‐injected with a therapeutic dose of unlabeled metoclopramide (10 mg). For both doses, elderly subjects had a significantly higher total volume of distribution (V T) of [11C]metoclopramide in the basal ganglia than young subjects (microdose: +26%, therapeutic dose: +41%). Increases in V T (= K 1/k 2) were caused by significant decreases in the transfer rate constant of [11C]metoclopramide from brain into plasma (k 2, microdose: −18%, therapeutic dose: −30%), whereas the distributional clearance from plasma into brain (K 1) remained unaltered. This reduction in the clearance of [11C]metoclopramide (k 2) from the brains of elderly subjects may be caused by an age‐related decrease in the activity of P‐gp at the BBB and may contribute to the higher incidence of CNS side effects of metoclopramide in the aged population. Our data suggest that an age‐associated decrease in the clearance properties of the BBB may modulate the CNS effects or side effects of clinically used P‐gp substrates.
DOI: 10.1097/mcg.0b013e3182522624
发表时间: 2012-07-01
影响因子: 2.9
作者:
Parkman, Henry P.;Mishra, Anurag;Krynetskiy, Evgeny
通讯作者: Krynetskiy, Evgeny
DOI: 10.1016/j.clpt.2006.02.004
发表时间: 2006-06-01
影响因子: 6.7
作者:
Toornvliet, Rolf;van Berckel, Bart N. M.;Franssen, Eric J. F.
通讯作者: Franssen, Eric J. F.
DOI: 10.1111/bcp.13301
发表时间: 2017-09-01
影响因子: 3.4
作者:
Bauer, Martin;Wulkersdorfer, Beatrix;Langer, Oliver
通讯作者: Langer, Oliver
DOI: 10.1089/bio.2018.0032
发表时间: 2018-10-18
影响因子: 1.6
作者:
Haslacher, Helmuth;Gerner, Marlene;Perkmann, Thomas
通讯作者: Perkmann, Thomas
DOI: 10.1124/dmd.104.001230
发表时间: 2005-01-01
影响因子: 3.9
作者:
Doran, A;Obach, RS;Zhang, CH
通讯作者: Zhang, CH